Revolution Medicines collects $25 mln
Redwood City, California-based Revolution Medicines Inc, a developer of cancer drugs, has secured $25 million in funding. The investors were The Column Group and Third Rock Ventures. Concurrent with the funding, Dr. Larry Lasky, a partner at The Column Group, has been added to Revolution Medicine's board of directors.
20 December 2016•3 mins read
